ArticleTechnology in cancer research & treatment
Longitudinal MRI Temporal Transformer Fusion Model for Predicting Induction Chemotherapy Efficacy in Locally Advanced Nasopharyngeal Carcinoma.
Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
IntroductionInduction chemotherapy (IC) represents a standard treatment approach for locally advanced nasopharyngeal carcinoma (LA-NPC), yet marked interpatient heterogeneity in treatment response persists. This study sought to develop and evaluate a temporal Transformer-based fusion model integrating baseline pretreatment and early intratreatment MRI to facilitate early risk stratification and inform individualized therapeutic management.Materials and MethodsIn this retrospective multicenter study, 488 patients with pathologically confirmed LA-NPC were enrolled from two institutions. All patients underwent induction chemotherapy and received contrast-enhanced T1-weighted imaging (CE-T1WI) before treatment initiation (Pre-IC) and at an early post-treatment time point (Post-IC). A dual-branch independent network architecture with Twins-SVT as the backbone was implemented to separately extract deep learning features from Pre-IC and Post-IC CE-T1WI images. Subsequently, an attention-based temporal Transformer fusion module was designed to model nonlinear longitudinal interactions and dynamic evolutionary patterns between pre- and post-treatment tumor representations, yielding a longitudinal temporal fusion predictive model. Gradient-weighted class activation mapping (Grad-CAM) was applied to enhance interpretability through visualization of salient imaging regions.ResultsThe deep learning model based on Pre-IC imaging yielded an AUC of 0.844 (95% CI: 0.767-0.922) in the internal validation cohort and 0.819 (95% CI: 0.725-0.913) in the external validation cohort. The Post-IC-based model demonstrated AUCs of 0.863 (95% CI: 0.790-0.936) and 0.838 (95% CI: 0.753-0.923) in the internal and external validation cohorts, respectively. The longitudinal temporal Transformer fusion model achieved higher predictive performance, with AUCs increasing to 0.889 (95% CI: 0.824-0.955) in the internal validation cohort and 0.865 (95% CI: 0.791-0.939) in the external validation cohort.ConclusionCompared with single-time point models, a longitudinal contrast-enhanced MRI-based temporal Transformer fusion model enabled more accurate early individualized prediction of induction chemotherapy response in patients with locally advanced nasopharyngeal carcinoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.